Literature DB >> 18194711

Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006.

David G Bostwick1, David J Waters, Edward R Farley, Isabelle Meiers, Daniel Rukstalis, William A Cavanaugh, Haakon Ragde, Martin K Dineen, Duke Bahn, Stephen Scionti, Richard Babian, David S Ellis, John C Rewcastle, Harry B Burke, Gerald L Andriole, Gary Onik, Al E Barqawi, John Maksem, Winston E Barzell.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18194711     DOI： 10.1016/j.urology.2007.07.037

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  20 in total

1.  Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers.

Authors:  Henk van der Poel; Laurence Klotz; Gerald Andriole; Abdel-Rahmène Azzouzi; Anders Bjartell; Olivier Cussenot; Freddy Hamdy; Markus Graefen; Paolo Palma; Arturo Rodriguez Rivera; Christian G Stief
Journal:  World J Urol       Date:  2015-06-03       Impact factor: 4.226

2.  Prostate cancer: a consensus on trial design for focal therapy.

Authors:  Sangeet Ghai; John Trachtenberg
Journal:  Nat Rev Urol       Date:  2014-03-18       Impact factor: 14.432

3.  Outcome of repeated prostatic biopsy during active surveillance: implications for focal therapy.

Authors:  Ghassan A Barayan; Armen G Aprikian; James Hanley; Wassim Kassouf; Fadi Brimo; Louis R Bégin; Simon Tanguay
Journal:  World J Urol       Date:  2014-11-12       Impact factor: 4.226

Review 4.  Focal therapy in prostate cancer: modalities, findings and future considerations.

Authors:  Uri Lindner; John Trachtenberg; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-09-14       Impact factor: 14.432

Review 5.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

6.  A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer.

Authors:  R van Velthoven; F Aoun; Q Marcelis; S Albisinni; M Zanaty; M Lemort; A Peltier; K Limani
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-11-24       Impact factor: 5.554

Review 7.  The prostate cancer focal therapy.

Authors:  Filippo Pesapane; Francesca Patella; Enrico Maria Fumarola; Edoardo Zanchetta; Chiara Floridi; Gianpaolo Carrafiello; Chloë Standaert
Journal:  Gland Surg       Date:  2018-04

8.  Focal cryoablation for unilateral low-intermediate-risk prostate cancer: 63-month mean follow-up results of 41 patients.

Authors:  Huibo Lian; Junlong Zhuang; Rong Yang; Feng Qu; Wei Wang; Tingsheng Lin; Hongqian Guo
Journal:  Int Urol Nephrol       Date:  2015-11-03       Impact factor: 2.370

9.  Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.

Authors:  Freddie C Hamdy; Jenny L Donovan; J Athene Lane; Malcolm Mason; Chris Metcalfe; Peter Holding; Julia Wade; Sian Noble; Kirsty Garfield; Grace Young; Michael Davis; Tim J Peters; Emma L Turner; Richard M Martin; Jon Oxley; Mary Robinson; John Staffurth; Eleanor Walsh; Jane Blazeby; Richard Bryant; Prasad Bollina; James Catto; Andrew Doble; Alan Doherty; David Gillatt; Vincent Gnanapragasam; Owen Hughes; Roger Kockelbergh; Howard Kynaston; Alan Paul; Edgar Paez; Philip Powell; Stephen Prescott; Derek Rosario; Edward Rowe; David Neal
Journal:  Health Technol Assess       Date:  2020-08       Impact factor: 4.014

10.  Anatomically versus biologically unifocal prostate cancer: a pathological evaluation in the context of focal therapy.

Authors:  Markos Karavitakis; Hashim U Ahmed; Paul D Abel; Steven Hazell; Mathias H Winkler
Journal:  Ther Adv Urol       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.